Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction

Bibliography

• PETERS-GOLDEN M, HENDERSON WR Jr: The role of leukotrienes in allergic rhinitis. Ann. Allergy Asthma Immunol. (2005) 94:609-618.
   PubMed Web of Science ®Google Scholar
• CURRIE GP, MCLAUGHLIN K: The expanding role of leukotriene receptor antagonists in chronic asthma. Ann. Allergy Asthma Immunol. (2006) 97:731-742.
   PubMed Web of Science ®Google Scholar
• OVERVIEW OF ALLERGIC DISEASES: Diagnosis, management, and barriers to care. In: The Allergy Report, Volume 1. American Academy of Allergy, Asthma and Immunology, Milwaukee, WI (2000).
   Google Scholar
• NAYAK A: A review of montelukast in the treatment of asthma and allergic rhinitis. Expert Opin. Pharmacother. (2004) 5(3):679-686.
   PubMed Web of Science ®Google Scholar
• AMERICAN LUNG ASSOCIATION, EPIDEMIOLOGY AND STATISTICS UNIT RESEARCH AND SCIENTIFIC AFFAIRS: Trends in Asthma Morbidity and Mortality American Lung Association, New York (2003).
   Google Scholar
• Pediatric Asthma: Promoting Best Practice Guide for Managing Asthma in Children. American Academy of Allergy, Asthma, and Immunology, Milwaukee, WI (1999).
   Google Scholar
• BUNDY DG: Hospitalizations with primary versus secondary discharge diagnoses of asthma: implications for pediatric asthma surveillance. J. Pediatr. (2007) 150:446-449.
   PubMed Web of Science ®Google Scholar
• Montelukast Package Insert. In: Physicians' Desk Reference. Edition 61, Thomson PDR (Ed.) Montvale, NJ (2007).
   Google Scholar
• CAPRA V: Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacol. Res. (2004) 50:1-11.
   PubMed Web of Science ®Google Scholar
• HUI Y, FUNK CD: Cysteinyl leukotriene receptors. Biochem. Pharmacol. (2002) 64(11):1549-1557.
   PubMed Web of Science ®Google Scholar
• JONES TR, LABELLE M, BELLEY M et al.: Pharmacology of montelukast sodium (Singluair™), a potent and selective leukotriene D4 receptor antagonist. Can. J. Physiol. Pharmacol. (1995) 73:191-201.
   PubMed Web of Science ®Google Scholar
• KNORR B, HOLLAND S, ROGERS JD, NGUYEN HH, REISS TF: Montelukast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selections. J. Allergy Clin. Immunol. (2000) 106(3): S171-S178.
   Google Scholar
• KNORR B, NGUYEN HH, KEARNS G et al.: Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults. J. Clin. Pharmacol. (2001) 41:612-619.
   PubMed Web of Science ®Google Scholar
• KNORR B, MAGANTI L, RAMAKRISHNAN R, TOZZI CA, MIGOYA E, KEARNS G: Pharmacokinetics in children aged 3 to 6 months. J. Clin. Pharm. (2006) 46:620-627.
   PubMed Web of Science ®Google Scholar
• NAYAK A, LANGDON RB: Montelukast in the treatment of allergic rhinitis: an evidence-based review. Drugs (2007) 67(6):887-901.
   PubMed Web of Science ®Google Scholar
• KNORR B, FRANCHI LM, BISGAARD H et al.: Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics (2001) 108(3):E48-E58.
   PubMed Web of Science ®Google Scholar
• KNORR B, MATZ J, BERNSTEIN JA et al.: Montelukast for chronic asthma in 6- to 14-year-old children. a randomized, double-blind trial. JAMA (1998) 279(15):1181-1186.
   PubMed Web of Science ®Google Scholar
• WILLIAMS B, NOONAN G, REISS TF et al.: Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. Clin. Exp. Allergy (2001) 31:845-854.
   PubMed Web of Science ®Google Scholar
• STELMACH I, JERZYNSKA J, KUNA, P: A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), solubel interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J. Allergy Clin. Immunol. (2002) 109(2):257-263.
   PubMed Web of Science ®Google Scholar
• PHIPATANAKUL W, NOWAK-WEGRZYN A, EGGLESTON PA et al.: The efficacy of montelukast in the treatment of cat allergen-induced asthma in children. J. Allergy Clin. Immunol. (2002) 109(5):794-799.
   PubMed Web of Science ®Google Scholar
• PHIPANTANAKUL W, GREENE C, DOWNES SJ et al.: Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids. Ann. Allergy Asthma Immunol. (2003) 91:49-54.
   PubMed Web of Science ®Google Scholar
• BISGAARD H, NIELSEN KG: Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. Am. J. Respir. Crit. Care. Med. (2000) 162:187-190.
   PubMed Web of Science ®Google Scholar
• RAZI C, BAKIRTAS A, HARMANCI K, TURKTAS I, ERBAS D: Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. (2006) 97:767-774.
   PubMed Web of Science ®Google Scholar
• KESKIN O, ALYAMAC E, TUNCER A, DOGAN C, ADALIOGLU G, SEKEREL BE: Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis? Pediatr. Allergy Immunol. (2006) 17:259-268.
   PubMed Web of Science ®Google Scholar
• CHEN S-T, LU K-H, SUN H-L, CHANG W-T, LUE K-H, CHOU M-C: Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2 – 6 year. Pediatr. Allergy Immunol. (2006) 17:49-54.
   PubMed Web of Science ®Google Scholar
• LEFF JA, BUSSE WW, PEARLMAN D et al.: Montelukast, a leukotriene-receptor antagonis, for the treatment of mild asthma and exercise-induced bronchoconstriction. N. Engl. J. Med. (1998) 339(3):147-152.
   PubMed Web of Science ®Google Scholar
• PEARLMAN DS, VAN ADELSBERG J, PHILIP G et al.: Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann. Allergy Asthma Immunol. (2006) 97:98-104.
   PubMed Web of Science ®Google Scholar
• REISS TF, HILL JB, HARMAN E et al.: Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax (1997) 52(12):1030-1035.
   PubMed Web of Science ®Google Scholar
• BRONSKY EA, KEMP JP, ZHANG J, GUERREIRO D, REISS TF: Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval. Clin. Pharmacol. Ther. (1997) 62:556-561.
   PubMed Web of Science ®Google Scholar
• STEINSHAMN S, SANDSUND M, SUE-CHU M, BJERMER L: Effects of montelukast on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction. Scand. J. Med. Sci. Sports (2002) 12:211-217.
   PubMed Web of Science ®Google Scholar
• HOLMGREN D, SIXT R: Effects of salbutamol inhalations on transcutaneous blood gases in children during the acute asthmatic attack: from acute deterioration to recovery. Acta Paediatr. (1994) 83:515-519.
   PubMed Web of Science ®Google Scholar
• EDELMAN JM, TURPIN JA, BRONSKY EA et al.: Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction: a randomized, double-blind trial. Ann. Intern. Med. (2000) 132(2):97-104.
   PubMed Web of Science ®Google Scholar
• VILLARAN C, O'NEILL SJ, HELBLING A et al.: Montelukast versus salmeterol inpatients with asthma and exercise-induced bronchoconstriction. J. Allergy Clin. Immunol. (1999) 104(3):547-553.
   PubMed Web of Science ®Google Scholar
• CORENO A, SKOWRONSKI M, KOTARU C, MCFADDEN ER Jr: Comparative effects of long-acting β2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. J. Allergy Clin. Immunol. (2000) 106(3):500-506.
   PubMed Web of Science ®Google Scholar
• STEINSHAMN S, SANDSUND M, SUE-CHU M, BJERMER L: Effects of montelukast and salmeterol on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction. Chest (2004) 126(4):1154-1160.
   PubMed Web of Science ®Google Scholar
• WAALKENS HJ, VEN ESSEN-ZANDVLIET EE, GERRITSEN J et al.: The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children. Dutch CNSLD Study Group. Eur. Respir. J. (1993) 6:652-656.
   PubMed Web of Science ®Google Scholar
• NATIONAL ASTHMA EDUCATION AND PREVENTION PROGRAM. EXPERT PANEL REPORT II: Guidelines for the diagnosis and management of asthma – update on selected topics 2002. National Heart Lung and Blood Institute, NIH.
   Google Scholar
• VIDAL C, FERNANDEZ-OVIDE E, PINEIRO J, NUNEZ R, GONZALEZ-QUINTELA M: Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction. Ann. Allergy Asthma Immunol. (2001) 86:655-658.
   PubMed Web of Science ®Google Scholar
• STORMS W, CHERVINSKY P, GHANNAM AF et al.: A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Respir. Med. (2004) 98:1051-1062.
   PubMed Web of Science ®Google Scholar
• MELO RE, SOLE D, NASPITZ CK: Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses. J. Allergy Clin. Immunol. (2003) 111(2):301-307.
   PubMed Web of Science ®Google Scholar
• DE BENEDICTIS FM, DEL GIUDICE MM, FORENZA N, DECIMO F, DE BENEDICTIS D, CAPRISTO A: Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children. Eur. Respir. J. (2006) 28(2):291-295.
   PubMed Web of Science ®Google Scholar
• PAJARON-FERNANDEZ M, GARCIA-RUBIA S, SANCHEZ-SOLIS M, GARCIA-MARCOS L: Montelukast administered in the morning or evening to prevent exercise-induced bronchoconstriction in children. Ped. Pulmonol. (2006) 41:222-227.
   PubMed Web of Science ®Google Scholar
• PERONI DG, PIACENTINI GL, RESS M et al.: Time efficacy of a single dose of montelukast on exercise-induced asthma in children. Ped. Allergy Immunol. (2002) 13:434-437.
   PubMed Web of Science ®Google Scholar
• KEMP JP, DOCKHORN RJ, SHAPIRO GG et al.: Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J. Pediatr. (1998) 133(3):424-428.
   PubMed Web of Science ®Google Scholar
• BARNES N, THOMAS M, PRICE D, TATE H: The national monetlukast survey. J. Allergy Clin. Immunol. (2005) 115(1):47-54.
   PubMed Web of Science ®Google Scholar
• BUKSTEIN DA, HENK HJ, LUSKIN AT: A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy. Clin. Ther. (2001) 23(9):1589-1600.
   PubMed Web of Science ®Google Scholar
• BUKSTEIN DA, LUSKIN AT, BERNSTEIN A: “Real-world” effectiveness of daily controller medicine in children with mild persistent asthma. Ann. Allergy Asthma Immunol. (2003) 90:543-549.
   PubMed Web of Science ®Google Scholar
• LUSKIN A, BUKSTEIN D, KOCEVAR VS, YIN DD: Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy. Ann. Allergy Asthma Immunol. (2005) 95:129-36.
   PubMed Web of Science ®Google Scholar
• LAKOMSKI PH, CHITRE M: Evaluation of the utilization pattenrs of leukotriene modifiers in a large managed care health plan. J. Managed Care Pharm. (2004) 10(2):115-121.
   Google Scholar
• PHILIP G, NAYAK AS, BERGER WE et al.: The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr. Med. Res. Opin. (2004) 20(10):1549-1558. (Same as #116 in Table 3 references).
   PubMed Web of Science ®Google Scholar
• VIRCHOW JC, BACHERT C: Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Respir. Med. (2006) 100:1952-1959.
   PubMed Web of Science ®Google Scholar
• BECKER AB, KUZNETSOVA O, VERMEULEN J et al.: Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study. Ann. Allergy Asthma Immunol. (2006) 96(6):800-807.
   PubMed Web of Science ®Google Scholar
• BISGAARD H, HERMANSEN MN, LOLAND L, HALKJAER LB, BUCHVALD F: Intermittent inhaled corticosteroids in infants with episodic wheezing. N. Engl. J. Med. (2006) 354(19):1998-2005.
   PubMed Web of Science ®Google Scholar
• GUILBERT TW, MORGAN WJ, ZEIGER RS et al.: Long-term inhaled corticosteroids in preschool children at high risk for asthma. N. Engl. J. Med. (2006) 354(19):1985-1997.
   PubMed Web of Science ®Google Scholar
• ZEIGER RS, SZEFLER SJ, PHILLIPS BR et al.: Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J. Allergy Clin. Immunol. (2006) 117(1):45-52.
   PubMed Web of Science ®Google Scholar
• JINDAHL SK: Dutch hypothesis revisited. Chest (2004) 126(2):329-331.
   PubMed Web of Science ®Google Scholar
• OGAWA Y, CALHOUN WJ: The role of leukotrienes in airway inflammation. J. Allergy Clin. Immunol. (2006) 118(4):789-798.
   PubMed Web of Science ®Google Scholar
• CIEBIADA M, GORSKA-CIEBIADA M, DUBUSKE LM, GORSKI P: Montelukast with desloratadine or levocabastine for the treatment of persistent allergic rhinitis. Ann. Allergy Asthma Immunol. (2006) 97:664-671.
   PubMed Web of Science ®Google Scholar
• LEE DKC, JACKSON CM, SOUTAR PC, FARDON TC, LIPWORTH BJ: Effects of single or combined histamine-H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis. Br. J. Clin. Pharmacol. (2004) 57(6):714-719.
   PubMed Web of Science ®Google Scholar
• PATEL P, PHILIP G, YANG W et al.: Randomized double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann. Allergy Asthma Immunol. (2005) 95:551-557.
   PubMed Web of Science ®Google Scholar
• CHERVINSKY P, PHILIP G, MALLICE M-P et al.: Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies. Ann. Allergy Asthma Immunol. (2004) 92:367-373.
   PubMed Web of Science ®Google Scholar
• DITTA V, MARTINELLI N, CANDORE G et al.: Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin. Exp. Allergy (2004) 34(2):259-267.
   PubMed Web of Science ®Google Scholar
• KUROWSKI M, KUNA P, GORSKI P: Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation. Allergy (2004) 59:280-288.
   PubMed Web of Science ®Google Scholar
• MARTIN BG, ANDREWS CP, VAN BAVEL JH et al.: Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Ann. Allergy Asthma Immunol. (2006) 96:851-857.
   PubMed Web of Science ®Google Scholar
• MELTZER EO, PHILIP G, WEINSTEIN SF et al.: Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis. Am. J. Rhinol. (2005) 19(6):591-598.
   PubMedGoogle Scholar
• MUCHA SM, DETINEO M, NACLERIO RM, BAROODY FM: Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Arch. Otolaryngol. Head Neck Surg. (2006) 132(2):164-172.
   Web of Science ®Google Scholar
• WEINSTEIN SF, PHILIP G, HAMPEL FC Jr et al.: Onset of efficacy of montelukast in seasonal allergic rhinitis. Allergy and Asthma Proc. (2005) 26(1):41-46.
   PubMed Web of Science ®Google Scholar
• DAVIS BE, TODD DC, COCKCROFT DW: Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen. J. Allergy Clin. Immunol. (2005) 116(4):768-772.
   PubMed Web of Science ®Google Scholar
• RAND C, BILDERBACK A, SCHILLER K et al.: Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J. Allergy Clin. Immunol. (2007) 119(4):916-923.
   PubMed Web of Science ®Google Scholar
• BUSSE WW, CASALE TB, DYKEWICA MS et al.: Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity. Ann. Allergy Asthma Immunol. (2006) 96:60-68.
   PubMed Web of Science ®Google Scholar
• PERRY TT, CORREN J, PHILIP G et al.: Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure. Ann. Allergy Asthma Immunol. (2004) 93:431-438.
   PubMed Web of Science ®Google Scholar
• PHILIP G, NAYAK AS, BERGER WE et al.: The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr. Med. Res. Opin. (2004) 20(10):1549-58.
   PubMed Web of Science ®Google Scholar
• PRICE DB, SWERN A, TOZZI CA, PHILIP G, POLOS P: Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy (2006) 61:737-742.
   PubMed Web of Science ®Google Scholar